Study to Evaluate the Immunogenicity and Safety of an Investigational Pandemic Influenza Vaccine in Children
NCT01323946
·
clinicaltrials.gov ↗
PHASE2
Phase
COMPLETED
Status
113
Enrollment
INDUSTRY
Sponsor class
Conditions
Influenza
Interventions
BIOLOGICAL:
GSK Biologicals' investigational vaccine GSK1562902A
Sponsor
GlaxoSmithKline